The prostate cancer screening controversy in perspective.
Where this comes from
- Record sourced from PubMed, PMID 9795486.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Until long-term ongoing trials show that screening for prostate cancer is beneficial and cost-effective, physicians should focus screening efforts on high-risk patients most likely to benefit from treatment, and inform patients about the pluses and minuses of current screening, diagnostic, and treatment methods.